Bartlett & CO. Wealth Management Trims Abbott Laboratories Holdings

Chicago-based firm reduces stake in healthcare giant by 1.5% in Q4 2025

Apr. 11, 2026 at 12:25pm

Got story updates? Submit your updates here. ›

An extreme close-up of a complex array of metal gears, cogs, and machinery, conveying the intricate, high-stakes nature of the financial industry without using any literal financial symbols or text.A glimpse into the powerful, institutional machinery of the financial industry, where investment decisions shape the fortunes of major corporations.Chicago Today

Bartlett & CO. Wealth Management LLC, a Chicago-based investment firm, reduced its stake in Abbott Laboratories (NYSE: ABT) by 1.5% during the fourth quarter of 2025, according to a recent SEC filing. The firm now owns 1,011,054 shares of the healthcare product maker, valued at approximately $126.7 million.

Why it matters

Abbott Laboratories is a major player in the healthcare industry, known for its diverse portfolio of medical devices, diagnostics, and nutritional products. Tracking institutional investor activity in the stock can provide insights into market sentiment and potential future performance.

The details

In its 13F filing, Bartlett & CO. Wealth Management reported selling 15,032 shares of Abbott Laboratories during the fourth quarter. The firm's total investment in the company now represents approximately 1.7% of its overall portfolio.

  • Bartlett & CO. Wealth Management filed its 13F report for the fourth quarter of 2025 on April 11, 2026.

The players

Bartlett & CO. Wealth Management LLC

A Chicago-based investment management firm that provides wealth management services to individuals and institutions.

Abbott Laboratories

A global healthcare company that develops, manufactures, and markets a broad portfolio of medical products and services, including diagnostics, medical devices, nutritionals, and established pharmaceuticals.

Got photos? Submit your photos here. ›

The takeaway

This filing provides a glimpse into the investment strategies of a prominent Chicago-based wealth management firm, highlighting their reduced exposure to a major healthcare company. Tracking such institutional activity can offer valuable insights into broader market trends and sentiment.